Skip to main content

Hepatopulmonary Syndrome clinical trials at UCSF

1 research study open to eligible people

Showing trials for
  • Letrozole in Patients With Hepatopulmonary Syndrome

    open to eligible people ages 18-99

    The purpose of this study is to assess the safety, tolerability and possible benefit of letrozole compared to placebo in patients with Hepatopulmonary Syndrome.

    San Francisco, California and other locations

Our lead scientists for Hepatopulmonary Syndrome research studies include .

Last updated: